Switzerland will get 4.5 million doses of the vaccine, enough to vaccinate 2.25 million people if as expected two doses are needed per patient.

Switzerland has signed an agreement with Moderna to secure early access to the COVID-19 vaccine the U.S. biotech company is developing, the government said on Friday. Switzerland will get 4.5 million doses of the vaccine, enough to vaccinate 2.25 million people if as expected two doses are needed per patient.
The government is also talking to other vaccine companies and has allocated 300 million Swiss francs ($329 million) to the project.
Get live Stock Prices from BSE, NSE, US Market and latest NAV, portfolio of Mutual Funds, calculate your tax by Income Tax Calculator, know market’s Top Gainers, Top Losers & Best Equity Funds. Like us on Facebook and follow us on Twitter.
Financial Express is now on Telegram. Click here to join our channel and stay updated with the latest Biz news and updates.